The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy

NCT05645198 — Phase 4, Unknown, 180 participants, Bucheon St. Mary's Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy: Single-center, Non-inferiority, Open-label Randomized Trial

RegistryNCT05645198, acronym OOZFIX
StatusUnknown
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: none, prevention
Enrollment180 (Estimated)
SponsorBucheon St. Mary's Hospital (Other)
ConditionsStomach Neoplasm
InterventionsOozfix, Greenplast (Drug)
Datesstart 2022-10-26, primary completion 2024-12-31 (estimated), completion 2025-01-31 (estimated), first posted 2022-12-09, last updated 2022-12-09
Locations1 site in South Korea

Related Papers Related Patents Related Grants Related Experts
All trials for Stomach Neoplasm All trials of Oozfix All trials of Greenplast

-Summary

Although the technique of radical gastrectomy had been advanced, postoperative complication can occur in 13\~25% of patient after radical gastrectomy. Pancreatic fistula and postoperative bleeding was reported as 2\~30% and 1\~2%, respectively. These complications often result fatal clinical course, so localized fibrin agent has been widely used at postoperative surgical bed after radical gastrectomy.

Recently, natural origin polysaccharide-based carboxymetyl starch was approved as localized coagulative, no well-designed report was adressed in gastric cancer surgery field. This agent can formate physical barrier after application, thus can prevent microbleeding or pancreatic fistula after gastrectomy. THIS study is single-center, non-inferiority, open-label randomized trial that evaluates the effect of carboxymetyl starch (Oozfix) on preventing postoperative complication after gastrectomy.

Expand all sections  ·  Collapse all

+Detailed description

Although the technique of radical gastrectomy had been advanced, postoperative complication can occur in 13\~25% of patient after radical gastrectomy. Pancreatic fistula and postoperative bleeding was reported as 2\~30% and 1\~2%, respectively. These complications often result fatal clinical course, so localized fibrin agent has been widely used at postoperative surgical bed after radical gastrectomy.

Recently, natural origin polysaccharide-based carboxymetyl starch was approved as localized coagulative, no well-designed report was adressed in gastric cancer surgery field. This agent can formate physical barrier after application, thus can prevent microbleeding or pancreatic fistula after gastrectomy. THIS study is single-center, non-inferiority, open-label randomized trial that evaluates the effect of carboxymetyl starch (Oozfix) on preventing postoperative complication after gastrectomy.

+Arms and interventions

ArmTypeInterventionsDescription
OozfixExperimentalDrug: OozfixArm with oozfix after gastrectomy
GreenplastActive comparatorDrug: GreenplastArm with greenplast after gastrectomy
  • Oozfix (Drug), also known as Case group: Directly apply carboxymetyl starch (Oozfix) 5 gram evenly at the suprapancreatic surgical bed after gastrectomy
  • Greenplast (Drug), also known as Control Group: Directly apply Greenplast (Aprotinin 1000kIU/mL, Thrombin 500IU/mL, Fibrinogen 95mg/mL) 4 gram evenly at the suprapancreatic surgical bed after gastrectomy

+Outcome measures

Primary outcomes

  • Ratio of (patient who suffers from) pancreatic fistula [Postoperative day 3]: Ratio of patient who suffers from pancreatic fistula

+Eligibility

Sex: All, ages: 19 Years to 80 Years

Inclusion Criteria:

1. Gastric adenocarcinoma patient who underwent radical gastrectomy at Bucheon St. Mary's Hospital
2. Patient's Age is above 19 and less than 80
3. ECOG performance score : 0\~2

Exclusion Criteria:

1. Patient who underwent emergent gastrectomy
2. Patient who requires palliative gastrectomy due to advanced or metastatic carcinoma
3. Patient who requires operation due to other malignancy other than adenocrcinoma
4. Patient who underwent emergent gastrectomy or pancreatectomy before this study
5. Patient who underwent chemoradiation
6. Patient who took anticoagulants or with coagulopathy

+Locations (1)

FacilityCityCountryStatus
BucheonStMarysBucheon-siSouth KoreaRecruiting

+Publications

  • Washio M, Yamashita K, Niihara M, Hosoda K, Hiki N. Postoperative pancreatic fistula after gastrectomy for gastric cancer. Ann Gastroenterol Surg. 2020 Sep 21;4(6):618-627. doi: 10.1002/ags3.12398. eCollection 2020 Nov. PMID 33319151

+Investigators

  • Hayemin LEE, Study chair, Bucheon St. Mary's Hospital